4 results on '"Jachno, Kim"'
Search Results
2. Medication use in infants admitted with bronchiolitis.
- Author
-
Oakley, Ed, Brys, Trusha, Borland, Meredith, Neutze, Jocelyn, Phillips, Natalie, Krieser, David, Dalziel, Stuart R, Davidson, Andrew, Donath, Susan, Jachno, Kim, South, Mike, Williams, Amanda, and Babl, Franz E
- Subjects
ADRENALINE ,ALBUTEROL ,ANTIBIOTICS ,STEROID drugs ,PHYSIOLOGIC salines ,BRONCHODILATOR agents ,IPRATROPIUM (Drug) ,HYPERTONIC saline solutions ,DRUG utilization ,INTENSIVE care units ,MEDICAL records ,BRONCHIOLE diseases ,RANDOMIZED controlled trials ,RETROSPECTIVE studies ,CHILDREN ,THERAPEUTICS - Abstract
Background: There are no medications known that improve the outcome of infants with bronchiolitis. Studies have shown the management of bronchiolitis to be varied. Objectives: To describe medication use at the seven study hospitals from a recent multi-centre randomised controlled trial on hydration in bronchiolitis (comparative rehydration in bronchiolitis [CRIB]). Methods: A retrospective analysis of extant data of infants between 2 months (corrected for prematurity) and 12 months of age admitted with bronchiolitis identified through the CRIB trial. CRIB study records, medical records, pathology and radiology databases were used to collect data using a standardised form and entered in a single site database. Medications investigated included salbutamol, adrenaline, steroids, ipratropium bromide, normal saline, hypertonic saline, steroids and antibiotics. Results: There were 3456 infants available for analysis, of which 42.0% received at least one medication during hospitalisation. Medication use varied by site between 27.0 and 48.7%. The most frequently used medication was salbutamol (25.5%). Medication use in general, and salbutamol use in particular, increased by 8.2 and 9.3%, respectively, per month after 4 months of age; from 22.9 and 3.6% at 4 months to 81.4 and 68.8% at 11 months. In infants admitted to the intensive care unit (ICU) compared with those not admitted to ICU 81.6 and 39.5%, respectively, received medication at one point during the hospital stay. Conclusions: Medication was used for infants with bronchiolitis frequently and variably in Australia and New Zealand. Medication use increased with age. Better strategies for translating evidence into practice are needed. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
3. Economic evaluation of nasogastric versus intravenous hydration in infants with bronchiolitis.
- Author
-
Oakley, Ed, Carter, Rob, Murphy, Bridie, Borland, Meredith, Neutze, Jocelyn, Acworth, Jason, Krieser, David, Dalziel, Stuart, Davidson, Andrew, Donath, Susan, Jachno, Kim, South, Mike, and Babl, Franz E
- Subjects
BRONCHIOLE diseases ,COST effectiveness ,ECONOMICS ,FLUID therapy ,HOSPITAL care ,INTRAVENOUS therapy ,MEDICAL needs assessment ,MEDICAL care costs ,NEONATAL intensive care ,RESEARCH funding ,RESPIRATORY infections ,NEONATAL intensive care units ,ACQUISITION of data ,NASOENTERAL tubes ,DIAGNOSIS ,THERAPEUTICS - Abstract
Objective Bronchiolitis is the most common lower respiratory tract infection in infants and the leading cause of hospitalisation. We aimed to assess whether intravenous hydration ( IVH) was more cost-effective than nasogastric hydration ( NGH) as a planned secondary economic analysis of a randomised trial involving 759 infants (aged 2-12 months) admitted to hospital with a clinical diagnosis of bronchiolitis and requiring non-oral hydration. No Australian cost data exist to aid clinicians in decision-making around interventions in bronchiolitis. Methods Cost data collections included hospital and intervention-specific costs. The economic analysis was reduced to a cost-minimisation study, focusing on intervention-specific costs of IVH versus NGH, as length of stay was equal between groups. All analyses are reported as intention to treat. Results Intervention costs were greater for IVH than NGH ($113 vs $74; cost difference of $39 per child). The intervention-specific cost advantage to NGH was robust to inter-site variation in unit prices and treatment activity. Conclusion Intervention-specific costs account for <10% of total costs of bronchiolitis admissions, with NGH having a small cost saving across all sites. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
4. Computed tomography for head injuries in children: Change in Australian usage rates over time.
- Author
-
Oakley, Ed, May, Rachel, Hoeppner, Tobias, Sinn, Kam, Furyk, Jeremy, Craig, Simon, Rosengarten, Pamela, Kochar, Amit, Krieser, David, Dalton, Sarah, Dalziel, Stuart, Neutze, Jocelyn, Cain, Tim, Jachno, Kim, and Babl, Franz E
- Subjects
COMPUTED tomography ,HOSPITALS ,MEDICAL referrals ,NEURORADIOLOGY ,NOSOLOGY ,POISSON distribution ,RESEARCH funding ,TIME ,HEAD injuries ,RETROSPECTIVE studies ,DESCRIPTIVE statistics - Abstract
Objective Paediatric head injury is a common presentation to the ED. North American studies demonstrate increasing use of computed tomography (CT) brain scan (CTB) to investigate head injury. No such data exists for Australian EDs. The aim of this study was to describe CTB use in head injury over time in eight Australian EDs. Methods Retrospective ED electronic database and medical imaging database audit was undertaken for the years 2001-2010 by International Classification of Diseases (ICD) 9 or 10 code for head injury in children <16 years. EDs and medical imaging departments of eight hospitals in Australia (five tertiary referral and three mixed departments). Data for ED presentations with head injury, and all CTB performed by medical imaging were merged to obtain a data set of CTB performed within 24 h for head injury-related attendances to the ED. Descriptive and comparative analysis of CTB rates was performed. Results The rate of CTB over the decade was 10.2% (95% confidence interval (CI) 9.9-10.5). The annual rate varied from 9.5% (95% CI 8.2-10.9) to 12.5% (95% CI 11.2-13.9). CTB use did not increase over time. Median year of age at time of CT scan was 4 years, with an interquartile range of 1.5-9.4 years. Overall there was a 9.2% increase in the CTB scan rate for every additional year of age at presentation (95% CI 6.6-12.1; P < 0.001). Conclusion CTB use in head injuries did not increase during the study period, and rates of CTB were less than reported for North America. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.